Morgan Stanley raised the firm’s price target on Colgate-Palmolive to $111 from $103 and keeps an Overweight rating on the shares. The company “posted strong Q2 upside” and “importantly” the high quality and balanced nature of the beat give visibility on sustained organic sales growth outperformance compared to peers, the analyst tells investors in a post-earnings note.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CL:
- Colgate-Palmolive downgraded to Hold from Buy at HSBC
- CL Earnings: Colgate-Palmolive Reports Better-than-Expected Q2 Results
- Options Volatility and Implied Earnings Moves Today, July 26, 2024
- Colgate-Palmolive reports Q2 base profit margin up 300 bps to 60.8%
- Colgate-Palmolive backs FY24 net sales growth view of 2%-5%
